Breast Cancer Risk Investigation in Grown-up Hodgkin Lymphoma Patients Treated With MBVD. Multicenter Retrospective Study on ≥200 Adult Female HL Patients Treated With ≥1 MBVD Cycle (NPLD, Bleomycin, Vinblastine, Dacarbazine). It Investigates Breast Cancer Incidence Post-treatment.

NCT07120217 · clinicaltrials.gov ↗
COMPLETED
Status
200
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Federico II University